BioSpace News Archive

Nonacus Ltd, a UK based precision medicine company and manufacturer of ultra-sensitive next-generation sequencing (NGS) products, has announced the launch of ExomeCG, a new product to simplify the generation and interpretation of molecular and cytogenomic data.

Syapse today announced the appointment of Thomas D. Brown, MD, MBA as its first Chief Medical Officer. Dr. Brown, an internationally renowned oncologist and cancer researcher, joins Syapse from the Swedish Cancer Institute (SCI) at Providence St. Joseph Health (PSJH), where he served as Executive Director of SCI, and led the establishment of the SCI Personalized Medicine Program

Investments will support key initiatives across the state including increasing access to health care, preventing prescription opioid misuse and supporting tobacco-free living for at-risk populations

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid (“HA”) technology platform, today announced plans to showcase its osteoarthritis pain management and joint preservation and restoration regenerative therapies at the Annual Scientific Meeting of the International Society for Hip Arthroscopy (ISHA)

Ironshore Pharmaceuticals Inc. (“Ironshore”), a wholly owned subsidiary of Highland Therapeutics Inc. and a leader in the commercialization of novel treatments for Attention-Deficit/Hyperactivity Disorder (“ADHD”), today announced that it will present two posters at the 66th Annual Meeting of the American Academy of Child & Adolescent Psychiatry (AACAP) in Chicago, October 14-19, 2019,

DionyMed Brands Inc. (“DionyMed” or the “Company“) (CSE: DYME; OTCQB: DYMEF), a multi-state cannabis brands, direct-to-consumer and distribution platform, announced today that Edward Fields, the Company’s CEO, and Mark Zinselmeier, the Company’s Interim COO, have both resigned effective immediately.

Technavio has been monitoring the global diabetic neuropathy drugs market since 2016 and the market is poised to grow by USD 866.72 million during 2019-2023, progressing at a CAGR of about 6% during the forecast period.

Pharmacy Becomes First in Oklahoma to Make Sustainable Shift

PetaGene announced today that their PetaSuite software has been selected to compress the genomics data sets for AstraZeneca’s Centre for Genomics Research (CGR).

Certara®, the global model-informed drug development and decision support leader, today announced that it is celebrating the 20th anniversary of its Simcyp® Consortium.